
How should we measure and report radiotherapy-induced xerostomia?
Publication
, Journal Article
Eisbruch, A; Rhodus, N; Rosenthal, D; Murphy, B; Rasch, C; Sonis, S; Scarantino, C; Brizel, D
Published in: Semin Radiat Oncol
July 2003
Xerostomia is commonly measured and graded using objective measures of major salivary gland output and observer-rated toxicity grading. The separation between the different grades is somewhat ambiguous in the current toxicity grading systems. We propose a new grading system based primarily on the functional deficits associated with xerostomia. Salivary flow rates have been added as a criterion to the grading system, notwithstanding the weak correlation reported in most studies between the symptoms and objective functional measures. In addition to the observer-rated toxicity grading, recording of patient-reported quality of life, using validated instruments, is encouraged.
Duke Scholars
Published In
Semin Radiat Oncol
DOI
ISSN
1053-4296
Publication Date
July 2003
Volume
13
Issue
3
Start / End Page
226 / 234
Location
United States
Related Subject Headings
- Xerostomia
- Salivary Glands
- Radiotherapy
- Radionuclide Imaging
- Radiation Injuries
- Quality of Life
- Oncology & Carcinogenesis
- Humans
- Head and Neck Neoplasms
- 3211 Oncology and carcinogenesis
Citation
APA
Chicago
ICMJE
MLA
NLM
Eisbruch, A., Rhodus, N., Rosenthal, D., Murphy, B., Rasch, C., Sonis, S., … Brizel, D. (2003). How should we measure and report radiotherapy-induced xerostomia? Semin Radiat Oncol, 13(3), 226–234. https://doi.org/10.1016/S1053-4296(03)00033-X
Eisbruch, Avraham, Nelson Rhodus, David Rosenthal, Barbara Murphy, Coen Rasch, Stephen Sonis, Charles Scarantino, and David Brizel. “How should we measure and report radiotherapy-induced xerostomia?” Semin Radiat Oncol 13, no. 3 (July 2003): 226–34. https://doi.org/10.1016/S1053-4296(03)00033-X.
Eisbruch A, Rhodus N, Rosenthal D, Murphy B, Rasch C, Sonis S, et al. How should we measure and report radiotherapy-induced xerostomia? Semin Radiat Oncol. 2003 Jul;13(3):226–34.
Eisbruch, Avraham, et al. “How should we measure and report radiotherapy-induced xerostomia?” Semin Radiat Oncol, vol. 13, no. 3, July 2003, pp. 226–34. Pubmed, doi:10.1016/S1053-4296(03)00033-X.
Eisbruch A, Rhodus N, Rosenthal D, Murphy B, Rasch C, Sonis S, Scarantino C, Brizel D. How should we measure and report radiotherapy-induced xerostomia? Semin Radiat Oncol. 2003 Jul;13(3):226–234.

Published In
Semin Radiat Oncol
DOI
ISSN
1053-4296
Publication Date
July 2003
Volume
13
Issue
3
Start / End Page
226 / 234
Location
United States
Related Subject Headings
- Xerostomia
- Salivary Glands
- Radiotherapy
- Radionuclide Imaging
- Radiation Injuries
- Quality of Life
- Oncology & Carcinogenesis
- Humans
- Head and Neck Neoplasms
- 3211 Oncology and carcinogenesis